v3.26.1
Stockholders’ Equity
 6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Stockholders’ Equity

9. Stockholders’ Equity

 

Common Stock

 

As of June 30, 2026, 4,494,994 shares of common stock were issued and outstanding, 241,260 shares of common stock were reserved for issuance upon the exercise of outstanding warrants, 1,005,223 shares of common stock were reserved for issuance under our 2015 Equity Incentive Plan, as amended (the “2015 Plan”) and our 2024 Equity Incentive Plan, as amended (the “2024 Plan”), and 256,999 shares were reserved for issuance under our 2023 Non-Employee Director Compensation Plan.

 

The following table describes the shares and warrants issued as part of our 2022 private placement:

 

Issuance of Common Stock  Issue Date  Shares
Issued		   Price per
share		   Warrants
Issued		   Warrant
Exercise
Price		   Warrant
Fair Value		 
Private Placement 2022  April 1, 2022   1,242,588   $4.62    124,258   $4.62   $3.91 

 

Amortization of the debt issuance costs for the Private Placement 2022 offering was recorded at $0 for the three and six months ended June 30, 2026, and at $31,539 and $42,052 for the three and six months ended June 30, 2025.

 

Warrants

 

The following sets forth the warrants to purchase our common stock that were outstanding as of June 30, 2026:

 

Warrants Outstanding  

Warrant

Exercise Price

   Warrant Expiry
 109,560   $4.62   March 30, 2027 (1)
 95,500   $4.00   March 30, 2027 (1)
 16,000   $9.00   March 30, 2027 (1)
 17,200   $12.50   March 30, 2027 (1)
 3,000   $15.00   March 30, 2027 (2)

 

(1)   Issued to the placement agent in connection with private placements of our convertible promissory notes.
     
(2)   Issued to certain 5% stockholders.

 

A summary of warrant activity during the six months ended June 30, 2026 and 2025 is as follows:

 

   Warrants 
Outstanding at January 1, 2026   241,260 
Exercised   - 
Outstanding and Exercisable at June 30, 2026   241,260 

 

   Warrants 
Outstanding at January 1, 2025   255,958 
Exercised   (14,698)
Outstanding and Exercisable at June 30, 2025   241,260